Levalbuterol Solution
Product Images NDC 72162-2082

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Levalbuterol (NDC 72162-2082). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl721622082)

Levalbuterol Inhalation Solution, USP 0.63 mg (0.021%) solution label for oral inhalation. Contains 25 sterile unit-dose vials, each 3 mL. Relabeled by Bryant Ranch Prepack, manufactured by The Ritedose Corporation. Includes storage instructions and active ingredient concentration.*

FDA Label Image

Chemical Structure (Levalbuterol Inhalation Solution Usp 1)

Chemical structure of Levalbuterol Hydrochloride, showing the molecular arrangement including hydroxyl groups, an aromatic ring, and associated hydrochloride component.*

FDA Label Image

Figure E1 (Levalbuterol Inhalation Solution Usp 10)

An instructional illustration showing parts of a respiratory inhalation device labeled as 'Mouthpiece' and 'Reservoir.' The image depicts the mouthpiece as a detachable tip and the main body labeled as the reservoir, indicating components relevant to use or assembly.*

FDA Label Image

Figure E2 (Levalbuterol Inhalation Solution Usp 11)

An instructional illustration showing a respiratory inhalation device with labeled parts: a face mask and a reservoir. The diagram highlights these components likely related to the administration of an inhalation solution.*

FDA Label Image

Figure F (Levalbuterol Inhalation Solution Usp 12)

An illustration showing a compressor device with nebulizer tubing attached, indicating setup for respiratory inhalation use of a medication solution such as Levalbuterol.*

FDA Label Image

Figure G1 (Levalbuterol Inhalation Solution Usp 13)

An instructional illustration showing a person using an inhalation device by placing the mouthpiece in their mouth and holding the reservoir. The image highlights the parts labeled as 'Mouthpiece' and 'Reservoir.'*

FDA Label Image

Figure G2 (Levalbuterol Inhalation Solution Usp 14)

An instructional illustration showing a face mask connected to a reservoir cup, which is attached to a bottle. The diagram highlights the components labeled as 'Face Mask' and 'Reservoir' indicating their connection for inhalation use.*

FDA Label Image

Figure 1 (Levalbuterol Inhalation Solution Usp 2)

A line graph showing mean change in FEV1 over 8 hours after treatment with different doses of Levalbuterol (Lev), Racemic Albuterol (Rac), and placebo (PBO). The y-axis represents mean change in FEV1 percentage, and the x-axis shows time in hours. Four treatment groups are plotted with distinct markers, demonstrating responses over time.*

FDA Label Image

Figure 2 (Levalbuterol Inhalation Solution Usp 3)

A line graph showing mean change in FEV1 (%) over 8 hours for different doses of Levalbuterol (1.25 mg and 0.63 mg), Racemic albuterol (2.5 mg), and placebo (PBO). The x-axis represents time in hours, and the y-axis indicates mean change in FEV1 percentage. The graph compares respiratory function changes over time among the treatment groups.*

FDA Label Image

Figure 3 (Levalbuterol Inhalation Solution Usp 4)

A line graph showing mean change in FEV1 (%) over time (hours) for different treatment groups including Levalbuterol at 0.63 mg and 0.31 mg, Racemic albuterol at 2.5 mg and 1.25 mg, and a placebo group. The graph plots time on the x-axis from 0 to 4 hours and mean change in FEV1 on the y-axis from -5% to 30%.*

FDA Label Image

Figure 4 (Levalbuterol Inhalation Solution Usp 5)

A line graph depicting mean change in FEV1 (%) over time (hours) for different treatments, including Levalbuterol at 0.63 mg and 0.31 mg, Racemic albuterol at 2.5 mg and 1.25 mg, and placebo. The graph tracks lung function response up to 4 hours post-dose, with FEV1 changes on the y-axis and time on the x-axis.*

FDA Label Image

Figure A (Levalbuterol Inhalation Solution Usp 6)

An instructional diagram showing a unit-dose vial with a shaded twist-off tab portion at the top. The illustration highlights the twist-off tab on both sides of the vial, with text indicating that the shaded area is the twist-off tab portion of the vial.*

FDA Label Image

Figure B (Levalbuterol Inhalation Solution Usp 7)

An instructional diagram showing a sealed pouch with a tear notch labeled 'TEAR AT SEAM' and an arrow pointing downward, indicating where to open the pouch.*

FDA Label Image

Figure C (Levalbuterol Inhalation Solution Usp 8)

An instructional black-and-white line drawing showing a hand holding a small ampule and twisting the top to open it. The diagram uses an arrow to indicate the direction in which to twist the ampule's neck. This image illustrates how to open the ampule for use, likely related to the Levalbuterol inhalation solution.*

FDA Label Image

Figure D (Levalbuterol Inhalation Solution Usp 9)

An instructional illustration showing a hand holding a vial positioned above a device labeled with a reservoir, indicating the vial is being poured or inserted into this reservoir, likely demonstrating preparation for respiratory inhalation solution use.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.